Canada markets closed

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6930-0.0238 (-3.32%)
At close: 4:00PM EDT
0.6991 +0.01 (+0.88%)
After hours: 07:53PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
3,408
446
0
0
0
Cost of Revenue
1,813
468
-
-
-
Gross Profit
1,595
-22
-
-
-
Operating Expenses
Research Development
25,932
17,050
22,230
43,415
3,946
Selling General and Administrative
123,685
86,552
30,512
34,227
6,099
Total Operating Expenses
149,617
103,602
52,742
77,642
10,045
Operating Income or Loss
-148,022
-103,624
-52,742
-77,642
-10,045
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
-2,086
-38,850
-27,745
-48,195
-
Income Before Tax
-150,059
-142,305
-80,029
-125,710
-9,993
Income Tax Expense
15
4
4
2
-
Income from Continuing Operations
-150,074
-142,309
-80,033
-125,712
-9,993
Net Income
-150,074
-142,309
-80,033
-125,712
-9,993
Net Income available to common shareholders
-150,074
-142,309
-80,033
-125,778
-9,993
Basic EPS
-
-2.12
-1.99
-5.74
-4.33
Diluted EPS
-
-2.12
-1.99
-5.74
-4.33
Basic Average Shares
-
67,157
40,229
21,901
2,305
Diluted Average Shares
-
67,157
40,229
21,901
2,305
EBITDA
-
-103,322
-52,479
-77,380
-9,948